1. Home
  2. AMST vs PRPO Comparison

AMST vs PRPO Comparison

Compare AMST & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amesite Inc.

AMST

Amesite Inc.

N/A

Current Price

$1.01

Market Cap

6.9M

Sector

Technology

ML Signal

N/A

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$27.16

Market Cap

42.0M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
AMST
PRPO
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
42.0M
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
AMST
PRPO
Price
$1.01
$27.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
108.6K
137.5K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
40.46
92.15
EPS
N/A
N/A
Revenue
$110,459.00
$24,049,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.77
52 Week Low
$0.77
$16.01
52 Week High
$3.90
$33.63

Technical Indicators

Market Signals
Indicator
AMST
PRPO
Relative Strength Index (RSI) 43.68 51.73
Support Level $0.90 $25.46
Resistance Level $1.09 $29.20
Average True Range (ATR) 0.06 1.90
MACD -0.01 -0.29
Stochastic Oscillator 5.88 31.15

Price Performance

Historical Comparison
AMST
PRPO

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

About PRPO Precipio Inc.

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Share on Social Networks: